
Robert Hickey
Examiner (ID: 19222)
| Most Active Art Unit | 2102 |
| Art Unit(s) | 2103, 2102, 2601, 2104 |
| Total Applications | 927 |
| Issued Applications | 860 |
| Pending Applications | 1 |
| Abandoned Applications | 66 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1040742
[patent_doc_number] => 06870040
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-22
[patent_title] => 'Nucleic acid sequence encoding lymphoma associated molecule BAL'
[patent_app_type] => utility
[patent_app_number] => 09/830762
[patent_app_country] => US
[patent_app_date] => 1999-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 35629
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/870/06870040.pdf
[firstpage_image] =>[orig_patent_app_number] => 09830762
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/830762 | Nucleic acid sequence encoding lymphoma associated molecule BAL | Oct 28, 1999 | Issued |
Array
(
[id] => 4376298
[patent_doc_number] => 06303362
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-16
[patent_title] => 'Adenoviral vector and methods for making and using the same'
[patent_app_type] => 1
[patent_app_number] => 9/428292
[patent_app_country] => US
[patent_app_date] => 1999-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 10731
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/303/06303362.pdf
[firstpage_image] =>[orig_patent_app_number] => 428292
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/428292 | Adenoviral vector and methods for making and using the same | Oct 26, 1999 | Issued |
Array
(
[id] => 1338267
[patent_doc_number] => 06585979
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-01
[patent_title] => 'HIV envelope polypeptides and immunogenic composition'
[patent_app_type] => B1
[patent_app_number] => 09/419362
[patent_app_country] => US
[patent_app_date] => 1999-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 31
[patent_no_of_words] => 61817
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/585/06585979.pdf
[firstpage_image] =>[orig_patent_app_number] => 09419362
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/419362 | HIV envelope polypeptides and immunogenic composition | Oct 14, 1999 | Issued |
Array
(
[id] => 1489964
[patent_doc_number] => 06416992
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-09
[patent_title] => 'Compositions and methods for producing recombinant adeno-associated virus'
[patent_app_type] => B1
[patent_app_number] => 09/417418
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12848
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/416/06416992.pdf
[firstpage_image] =>[orig_patent_app_number] => 09417418
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/417418 | Compositions and methods for producing recombinant adeno-associated virus | Oct 12, 1999 | Issued |
Array
(
[id] => 4285894
[patent_doc_number] => 06268199
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof'
[patent_app_type] => 1
[patent_app_number] => 9/297535
[patent_app_country] => US
[patent_app_date] => 1999-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10910
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268199.pdf
[firstpage_image] =>[orig_patent_app_number] => 297535
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/297535 | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof | Oct 11, 1999 | Issued |
Array
(
[id] => 1469500
[patent_doc_number] => 06406862
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Dip-stick assay for C-reactive protein'
[patent_app_type] => B1
[patent_app_number] => 09/413361
[patent_app_country] => US
[patent_app_date] => 1999-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2775
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/406/06406862.pdf
[firstpage_image] =>[orig_patent_app_number] => 09413361
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/413361 | Dip-stick assay for C-reactive protein | Oct 5, 1999 | Issued |
Array
(
[id] => 1588297
[patent_doc_number] => 06482587
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-19
[patent_title] => 'Methods to inhibit or enhance the binding of viral DNA to genomic host DNA'
[patent_app_type] => B1
[patent_app_number] => 09/410399
[patent_app_country] => US
[patent_app_date] => 1999-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15460
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482587.pdf
[firstpage_image] =>[orig_patent_app_number] => 09410399
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/410399 | Methods to inhibit or enhance the binding of viral DNA to genomic host DNA | Sep 30, 1999 | Issued |
Array
(
[id] => 4406748
[patent_doc_number] => 06309817
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Identification of virulence determinants activators in prokaryotic pathogens'
[patent_app_type] => 1
[patent_app_number] => 9/408618
[patent_app_country] => US
[patent_app_date] => 1999-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12019
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/309/06309817.pdf
[firstpage_image] =>[orig_patent_app_number] => 408618
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/408618 | Identification of virulence determinants activators in prokaryotic pathogens | Sep 29, 1999 | Issued |
Array
(
[id] => 4266047
[patent_doc_number] => 06306663
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'Controlling protein levels in eucaryotic organisms'
[patent_app_type] => 1
[patent_app_number] => 9/406781
[patent_app_country] => US
[patent_app_date] => 1999-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 29628
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/306/06306663.pdf
[firstpage_image] =>[orig_patent_app_number] => 406781
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/406781 | Controlling protein levels in eucaryotic organisms | Sep 27, 1999 | Issued |
Array
(
[id] => 1514260
[patent_doc_number] => 06420122
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'Methods of screening for agents that inhibit aggregation of polypeptides'
[patent_app_type] => B1
[patent_app_number] => 09/405048
[patent_app_country] => US
[patent_app_date] => 1999-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9049
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420122.pdf
[firstpage_image] =>[orig_patent_app_number] => 09405048
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/405048 | Methods of screening for agents that inhibit aggregation of polypeptides | Sep 26, 1999 | Issued |
Array
(
[id] => 1483809
[patent_doc_number] => 06365154
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Tie2 agonist antibodies'
[patent_app_type] => B1
[patent_app_number] => 09/406532
[patent_app_country] => US
[patent_app_date] => 1999-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14009
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365154.pdf
[firstpage_image] =>[orig_patent_app_number] => 09406532
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/406532 | Tie2 agonist antibodies | Sep 26, 1999 | Issued |
Array
(
[id] => 1370322
[patent_doc_number] => 06558671
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-06
[patent_title] => 'Cysteine-depleted peptides recognized by A3-restricted cytotoxic lymphocytes, and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/341982
[patent_app_country] => US
[patent_app_date] => 1999-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 26705
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/558/06558671.pdf
[firstpage_image] =>[orig_patent_app_number] => 09341982
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/341982 | Cysteine-depleted peptides recognized by A3-restricted cytotoxic lymphocytes, and uses therefor | Sep 19, 1999 | Issued |
| 09/396296 | DELIVERY OF PHOSPHOINOSITIDE POLYPHOSPHATES INTO CELLS | Sep 14, 1999 | Abandoned |
Array
(
[id] => 742018
[patent_doc_number] => 07030235
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-04-18
[patent_title] => 'Compositions to detect lesions associated with hearing loss in the cochlear gene, COCH5B2'
[patent_app_type] => utility
[patent_app_number] => 09/394264
[patent_app_country] => US
[patent_app_date] => 1999-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 7
[patent_no_of_words] => 32284
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/030/07030235.pdf
[firstpage_image] =>[orig_patent_app_number] => 09394264
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/394264 | Compositions to detect lesions associated with hearing loss in the cochlear gene, COCH5B2 | Sep 9, 1999 | Issued |
| 09/393996 | NOVEL GENES ENCODING PROTEINS HAVING PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC, AND OTHER USES | Sep 9, 1999 | Abandoned |
Array
(
[id] => 4338644
[patent_doc_number] => 06284249
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Fusion polypeptide having the C protein and E1 protein of hepatitis C virus'
[patent_app_type] => 1
[patent_app_number] => 9/388874
[patent_app_country] => US
[patent_app_date] => 1999-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12584
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284249.pdf
[firstpage_image] =>[orig_patent_app_number] => 388874
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/388874 | Fusion polypeptide having the C protein and E1 protein of hepatitis C virus | Sep 1, 1999 | Issued |
Array
(
[id] => 1403742
[patent_doc_number] => 06528057
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'Method for removal of HIV and other viruses from blood'
[patent_app_type] => B1
[patent_app_number] => 09/385166
[patent_app_country] => US
[patent_app_date] => 1999-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 5018
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528057.pdf
[firstpage_image] =>[orig_patent_app_number] => 09385166
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/385166 | Method for removal of HIV and other viruses from blood | Aug 29, 1999 | Issued |
Array
(
[id] => 4246084
[patent_doc_number] => 06221662
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => 'Tryptamine treated, human differentiated, neuronal alzheimer-like cell and attendant methods of cell modeling'
[patent_app_type] => 1
[patent_app_number] => 9/384869
[patent_app_country] => US
[patent_app_date] => 1999-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3565
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/221/06221662.pdf
[firstpage_image] =>[orig_patent_app_number] => 384869
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/384869 | Tryptamine treated, human differentiated, neuronal alzheimer-like cell and attendant methods of cell modeling | Aug 26, 1999 | Issued |
Array
(
[id] => 1157045
[patent_doc_number] => 06765088
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-20
[patent_title] => 'Immunological detection of prions'
[patent_app_type] => B1
[patent_app_number] => 09/380015
[patent_app_country] => US
[patent_app_date] => 1999-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 14251
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/765/06765088.pdf
[firstpage_image] =>[orig_patent_app_number] => 09380015
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380015 | Immunological detection of prions | Aug 22, 1999 | Issued |
Array
(
[id] => 1476910
[patent_doc_number] => 06344192
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-05
[patent_title] => 'Use of interleukin-15'
[patent_app_type] => B1
[patent_app_number] => 09/380049
[patent_app_country] => US
[patent_app_date] => 1999-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8804
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/344/06344192.pdf
[firstpage_image] =>[orig_patent_app_number] => 09380049
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380049 | Use of interleukin-15 | Aug 22, 1999 | Issued |